Institutional Ownership
Bridgebio Pharma Inc
CUSIP 10806XAJ1NOTE 1.750% 3/0Q1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Diadema Partners LP | 250.0K | $18.57M |
| 2 | Ssi Investment Management LLC | 4.13M | $7.01M |
| 3 | State Of Wisconsin Investment Board | 3.00M | $5.08M |
| 4 | Bank Of New York Mellon Corp | 200.0K | $339.9K |